Compare · BTSG vs LFMD
BTSG vs LFMD
Side-by-side comparison of BrightSpring Health Services Inc. (BTSG) and LifeMD Inc. (LFMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BTSG and LFMD operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- BTSG is the larger of the two at $11.32B, about 72.3x LFMD ($156.7M).
- LFMD has been more active in the news (8 items in the past 4 weeks vs 1 for BTSG).
- BTSG has more recent analyst coverage (23 ratings vs 11 for LFMD).
- Company
- BrightSpring Health Services Inc.
- LifeMD Inc.
- Price
- $57.26-3.76%
- $3.26+3.66%
- Market cap
- $11.32B
- $156.7M
- 1M return
- -20.43%
- -
- 1Y return
- +139.13%
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- News (4w)
- 1
- 8
- Recent ratings
- 23
- 11
LifeMD Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.
Latest BTSG
- Amendment: SEC Form SCHEDULE 13G/A filed by BrightSpring Health Services Inc.
- SEC Form 10-Q filed by BrightSpring Health Services Inc.
- BrightSpring Health Services Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
- Officer Rousseau Jon B covered exercise/tax liability with 56,319 shares, decreasing direct ownership by 5% to 1,138,184 units (SEC Form 4) to cover withholding tax
- BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600
- Guggenheim initiated coverage on BrightSpring Health Services with a new price target
- Raymond James initiated coverage on BrightSpring Health Services with a new price target
- BrightSpring Health Services, Inc. to Announce Second Quarter 2026 Financial Results on July 31, 2026
- President, PharMerica Greenwell Scott A. covered exercise/tax liability with 2,487 shares, decreasing direct ownership by 7% to 34,372 units (SEC Form 4) to satisfy withholding obligation
Latest LFMD
- Director Larovere Joan was granted 35,000 shares, increasing direct ownership by 33% to 142,050 units (SEC Form 4)
- Director Strawn John R Jr was granted 85,000 shares, increasing direct ownership by 21% to 498,001 units (SEC Form 4)
- Director Ditrolio Joseph was granted 35,000 shares, increasing direct ownership by 13% to 308,413 units (SEC Form 4)
- Amendment: Director Simon Roberto was granted 80,810 shares, increasing direct ownership by 81% to 180,810 units (SEC Form 4)
- Director Simon Roberto was granted 85,000 shares, increasing direct ownership by 42% to 288,175 units (SEC Form 4)
- Director Macrae Calum Archibald was granted 35,000 shares, increasing direct ownership by 90% to 73,865 units (SEC Form 4)
- SEC Form 10-Q filed by LifeMD Inc.
- LifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- LifeMD to Report Second Quarter 2026 Financial Results on August 5
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock